Concept information
Preferred term
Amantadine
Type
-
mesh:Descriptor
Definition
- An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.
Broader concept
Narrower concepts
Entry terms
- 1-Aminoadamantane
- 665-66-7 (HCl)
- 768-94-5 (Amantadine)
- 9921T5P019
- Adamantylamine
- BF4C9Z1J53
- M6Q1EO9TD0
- Tricyclo(3.3.1.13,7)decan-1-amine
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
665-66-7 (HCl)
-
768-94-5 (Amantadine)
-
9921T5P019
-
BF4C9Z1J53
-
M6Q1EO9TD0
-
Tricyclo(3.3.1.13,7)decan-1-amine
URI
http://data.loterre.fr/ark:/67375/JVR-HLP1TTBK-Z
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}